<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Rosuvastatin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Rosuvastatin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Rosuvastatin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Rosuvastatin</b>, sold under the trade name <b>Crestor</b> among others, is a statin medication, used to prevent cardiovascular disease in those at high risk and treat abnormal lipids.<span class="mw-ref" id="cite_ref-AHFS2018_3-5"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is recommended to be used together with dietary changes, exercise, and weight loss.<span class="mw-ref" id="cite_ref-AHFS2018_3-6"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2018_3-7"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>



<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Rosuvastatin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Rosuvastatin_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rosuvastatin_structure.svg.png" data-file-width="512" data-file-height="237" data-file-type="drawing" height="127" width="275"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Rosuvastatin-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rosuvastatin-3D-balls.png" data-file-width="1047" data-file-height="593" data-file-type="bitmap" height="156" width="275"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>r</span><span>oʊ</span><span>ˈ</span><span>s</span><span>uː</span><span>v</span><span>ə</span><span>s</span><span>t</span><span>æ</span><span>t</span><span>ɪ</span><span>n</span></span>/</span></span> <i title="English pronunciation respelling">roh-<span style="font-size:90%">SOO</span>-və-stat-in</i><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Crestor, Rosulip, Zuvamor, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Rosuvastatin calcium (USAN <small><abbr>US</abbr></small>)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/rosuvastatin-calcium.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/rosuvastatin-calcium.html'" tppabs="https://www.drugs.com/monograph/rosuvastatin-calcium.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a603033.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a603033.html'" tppabs="https://medlineplus.gov/druginfo/meds/a603033.html" class="external text external">a603033</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Rosuvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Rosuvastatin'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Rosuvastatin" class="external text external">Rosuvastatin</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth (tablets)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>C10AA07<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10AA07  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10AA07'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10AA07" class="external text external">WHO</a></span>)<span> </span>A10BH52<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A10BH52  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A10BH52'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A10BH52" class="external text external">WHO</a></span>) C10BX05<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX05'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX05" class="external text external">WHO</a></span>) C10BX09<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX09  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX09'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX09" class="external text external">WHO</a></span>) C10BA06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BA06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BA06'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BA06" class="external text external">WHO</a></span>) C10BA09<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BA09  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BA09'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BA09" class="external text external">WHO</a></span>) C10BX16<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX16'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX16" class="external text external">WHO</a></span>) C10BA07<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BA07  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BA07'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BA07" class="external text external">WHO</a></span>) C10BX17<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX17  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX17'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX17" class="external text external">WHO</a></span>) C10BX10<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX10  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX10'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX10" class="external text external">WHO</a></span>) C10BX07<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX07  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX07'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX07" class="external text external">WHO</a></span>) C10BX14<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX14  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX14'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX14" class="external text external">WHO</a></span>) C10BX13<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX13  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX13'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX13" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>20%<span class="mw-ref" id="cite_ref-PK_2-0"><a href="#cite_note-PK-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2018_3-0"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>88%<span class="mw-ref" id="cite_ref-PK_2-1"><a href="#cite_note-PK-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2018_3-1"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver: CYP2C9 (major) and CYP2C19-mediated; ~10% metabolized<span class="mw-ref" id="cite_ref-PK_2-2"><a href="#cite_note-PK-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2018_3-2"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td><i>N</i>-desmethyl rosuvastatin (major; 1/6–1/9 of rosuvastatin activity)<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-0"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>19 hours<span class="mw-ref" id="cite_ref-PK_2-3"><a href="#cite_note-PK-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2018_3-3"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Feces (90%)<span class="mw-ref" id="cite_ref-PK_2-4"><a href="#cite_note-PK-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2018_3-4"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(3<i>R</i>,5<i>S</i>,6<i>E</i>)-7-[4-(4-Fluorophenyl)-2-(<i>N</i>-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=287714-41-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=287714-41-4'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=287714-41-4" class="external text external">287714-41-4</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/446157  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/446157'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/446157" class="external text external">446157</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2954  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2954'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2954" class="external text external">2954</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01098'" tppabs="https://www.drugbank.ca/drugs/DB01098" class="external text external">DB01098</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.393589.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.393589.html'" tppabs="http://www.chemspider.com/Chemical-Structure.393589.html" class="external text external">393589</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=413KH5ZJ73  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=413KH5ZJ73'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=413KH5ZJ73" class="external text external">413KH5ZJ73</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D01915  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D01915'" tppabs="https://www.kegg.jp/entry/D01915" class="external text external">D01915</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:38545  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:38545'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:38545" class="external text external">CHEBI:38545</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1496  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1496'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1496" class="external text external">ChEMBL1496</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>FBI (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=FBI  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=FBI'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=FBI" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=FBI&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=FBI&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=FBI&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID8048492  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID8048492'" tppabs="https://comptox.epa.gov/dashboard/DTXSID8048492" class="external text external">DTXSID8048492</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.216.011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.216.011'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.216.011" class="external text external">100.216.011</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>22</sub><span>H</span><sub>28</sub><span>F</span><span>N</span><sub>3</sub><span>O</span><sub>6</sub><span>S</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td>481.539<span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%28%3DO%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29%5CC%3DC%5Cc1c%28C%28C%29C%29nc%28N%28C%29S%28%3DO%29%28%3DO%29C%29nc1c2ccc%28F%29cc2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%28%3DO%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29%5CC%3DC%5Cc1c%28C%28C%29C%29nc%28N%28C%29S%28%3DO%29%28%3DO%29C%29nc1c2ccc%28F%29cc2'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%28%3DO%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29%5CC%3DC%5Cc1c%28C%28C%29C%29nc%28N%28C%29S%28%3DO%29%28%3DO%29C%29nc1c2ccc%28F%29cc2" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">OC(=O)C[C@H](O)C[C@H](O)\C=C\c1c(C(C)C)nc(N(C)S(=O)(=O)C)nc1c2ccc(F)cc2</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:BPRHUIZQVSMCRT-VEUZHWNKSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464383832&page2=Rosuvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464383832&page2=Rosuvastatin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464383832&page2=Rosuvastatin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include abdominal pain, nausea, headaches, and muscle pains.<span class="mw-ref" id="cite_ref-AHFS2018_3-8"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Serious side effects may include rhabdomyolysis, liver problems, and diabetes.<span class="mw-ref" id="cite_ref-AHFS2018_3-9"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Use during pregnancy may harm the baby.<span class="mw-ref" id="cite_ref-AHFS2018_3-10"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Like all statins, rosuvastatin works by inhibiting HMG-CoA reductase, an enzyme found in the liver that plays a role in producing <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a>.<span class="mw-ref" id="cite_ref-AHFS2018_3-11"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

 
<p>Rosuvastatin was patented in 1991, and approved for medical use in the United States in 2003.<span class="mw-ref" id="cite_ref-AHFS2018_3-12"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Fis2006_5-0"><a href="#cite_note-Fis2006-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2018_3-13"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In 2017, it was the 39th most commonly prescribed medication in the United States, with more than 19<span class="nowrap"><span>&nbsp;</span></span>million prescriptions.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Crestor_Tablets_(rosuvastatin).jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Crestor_Tablets_(rosuvastatin).jpg" data-file-width="3418" data-file-height="2278" data-file-type="bitmap" height="147" width="220"><div class="thumbcaption" style="text-align: left">Rosuvastatin (marketed as Crestor) 10 mg tablets</div></div></div>

<p>The primary use of rosuvastatin is for prevention of cardiovascular disease in those at high risk and the treatment of abnormal lipids.<span class="mw-ref" id="cite_ref-AHFS2018_3-14"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Effects_on_cholesterol_levels">Effects on cholesterol levels</h3></summary>
    
<p>The effects of rosuvastatin on low-density lipoprotein (LDL) cholesterol are dose-related. Higher doses were more efficacious in improving the lipid profile of patients with hypercholesterolemia than milligram-equivalent doses of <a href="Atorvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Atorvastatin" title="Atorvastatin">atorvastatin</a> and milligram-equivalent or higher doses of <a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">simvastatin</a> and <a href="Pravastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pravastatin" title="Pravastatin">pravastatin</a>.<span class="mw-ref" id="cite_ref-Jones-2003_8-0"><a href="#cite_note-Jones-2003-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Meta-analysis showed that rosuvastatin is able to modestly increase levels of high-density lipoprotein (HDL) cholesterol as well, as with other statins.<span class="mw-ref" id="cite_ref-pmid=18553127_9-0"><a href="#cite_note-pmid=18553127-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> A 2014 Cochrane review determined there was good evidence for rosuvastatin lowering non-HDL levels linearly with dose.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span>  HDL increases by 7% with no dose effect noted.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects_and_contraindications">Side effects and contraindications</h2></summary>
    
<p>Side effects are uncommon. The following side effects should be reported to the prescribing doctor if they persist or get worse:<span class="mw-ref" id="cite_ref-MedLine_11-0"><a href="#cite_note-MedLine-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>
<ul><li>constipation</li>
<li>heartburn</li>
<li>dizziness</li>
<li>sleeplessness</li>
<li>depression</li>
<li>joint pain</li>
<li>cough</li>
<li>memory loss or forgetfulness</li>
<li>confusion</li></ul>

<p>The following rare side effects are more serious. Like all statins, rosuvastatin can possibly cause myopathy, rhabdomyolysis. Stop taking rosuvastatin and contact the prescribing doctor if any of these occur:<span class="mw-ref" id="cite_ref-MedLine_11-1"><a href="#cite_note-MedLine-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-1"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>
<ul><li>muscle pain, tenderness, or weakness</li>
<li>lack of energy</li>
<li>fever</li>
<li>chest pain</li>
<li>jaundice: yellowing of the skin or eyes</li>
<li>dark colored, or foamy urine</li>
<li>pain in the upper right part of the abdomen</li>
<li>nausea</li>
<li>extreme tiredness</li>
<li>weakness</li>
<li>unusual bleeding or bruising</li>
<li>loss of appetite</li>
<li>flu-like symptoms</li>
<li>sore throat, chills, or other signs of infection</li></ul>

<p>If any signs of an allergic reaction develop, contact an emergency medical service immediately:<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-2"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>
<ul><li>rash</li>
<li>hives</li>
<li>itching</li>
<li>difficulty breathing or swallowing</li>
<li>swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs</li>
<li>hoarseness</li>
<li>numbness or tingling in fingers or toes</li></ul>

<p>Rosuvastatin has multiple contraindications, conditions that warrant withholding treatment with rosuvastatin, including hypersensitivity to rosuvastatin or any component of the formulation, active liver disease, elevation of serum transaminases, pregnancy, or breastfeeding.<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-3"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Rosuvastatin must not be taken while pregnant as it can cause serious harm to the baby.<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-4"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In the case of breastfeeding, it is unknown whether rosuvastatin is passed through breastmilk but, due to the potential of disrupting the infant's lipid metabolism, patients should not breast feed while on rosuvastatin.<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-5"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-LactMed_12-0"><a href="#cite_note-LactMed-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>The risk of myopathy may be increased in Asian Americans: "Because Asians appear to process the drug differently, half the standard dose can have the same cholesterol-lowering benefit in those patients, though a full dose could increase the risk of side-effects, a study by the drug's manufacturer, AstraZeneca, indicated."<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Therefore, the lowest dose is recommended in Asians.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Myopathy">Myopathy</h3></summary>
    
<p>As with all statins, there is a concern of rhabdomyolysis, a severe undesired side effect. The U.S. Food and Drug Administration (FDA) has indicated that "it does not appear that the risk [of rhabdomyolysis] is greater with Crestor than with other marketed statins", but has mandated that a warning about this side-effect, as well as a kidney toxicity warning, be added to the product label.<span class="mw-ref" id="cite_ref-FDAlabel_17-0"><a href="#cite_note-FDAlabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-FDA_Rosuvastatin_Safety_18-0"><a href="#cite_note-FDA_Rosuvastatin_Safety-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Diabetes_mellitus">Diabetes mellitus</h3></summary>
    
<p>Statins increase the risk of diabetes,<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> consistent with FDA's review, which reported a 27% increase in investigator-reported diabetes mellitus in rosuvastatin-treated people.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Drug_interactions">Drug interactions</h2></summary>
    
<p>The following drugs can have negative interactions with rosuvastatin and should be discussed with the prescribing doctor:<span class="mw-ref" id="cite_ref-MedLine_11-2"><a href="#cite_note-MedLine-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-6"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>
<ul><li>Coumarin anticoagulants ('blood thinners', e.g. <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a>) can affect the removal of rosuvastatin</li>
<li><a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciclosporin" title="Ciclosporin">Ciclosporin</a>, <a href="Colchicine.htm" tppabs="https://ptable.com/wiki/compounds/A/Colchicine" title="Colchicine">colchicine</a></li>
<li>Drugs that may decrease the levels or activity of endogenous steroid hormones, e.g. <a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">cimetidine</a>, <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a>, and <a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">spironolactone</a></li>
<li>Additional medications for high cholesterol such as <a href="Clofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofibrate" title="Clofibrate">clofibrate</a>, <a href="Fenofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenofibrate" title="Fenofibrate">fenofibrate</a>, <a href="Gemfibrozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemfibrozil" title="Gemfibrozil">gemfibrozil</a>, and <a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">niacin</a> (when taken in lipid-modifying doses of 1 g/day and above)</li>
<li>Specific protease inhibitors including <a href="Atazanavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Atazanavir" title="Atazanavir">atazanavir</a> (when taken with <a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">ritonavir</a>), lopinavir/ritonavir and simeprevir</li>
<li>Alcohol intake should be reduced while on rosuvastatin in order to decrease risk of developing liver damage<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-7"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></li>
<li>Aluminum and magnesium hydroxide antacids should not be taken within two hours of taking rosuvastatin<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-8"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></li>
<li>Coadministration of rosuvastatin with eluxadoline may increase the risk of rhabdomyolysis and myopathy<span class="mw-ref" id="cite_ref-Viberzi_FDA_label_21-0"><a href="#cite_note-Viberzi_FDA_label-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Structure">Structure</h2></summary>
    
<p>Rosuvastatin has structural similarities with most other synthetic statins, e.g., <a href="Atorvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Atorvastatin" title="Atorvastatin">atorvastatin</a>, <a href="Cerivastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cerivastatin" title="Cerivastatin">cerivastatin</a> and pitavastatin, but unlike other statins, rosuvastatin contains <a href="Sulfur.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfur" title="Sulfur">sulfur</a> (in sulfonyl functional group).</p>

<p>Crestor is actually a <a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">calcium</a> salt of rosuvastatin, i.e. rosuvastatin calcium,<span class="mw-ref" id="cite_ref-FDAlabel_17-1"><a href="#cite_note-FDAlabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> in which calcium replaces the hydrogen in the carboxylic acid group on the right of the skeletal formula at the top right of this page.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    


<p>Rosuvastatin is a competitive inhibitor of the enzyme HMG-CoA reductase, having a mechanism of action similar to that of other statins.<span class="mw-ref" id="cite_ref-ASTEROID_22-0"><a href="#cite_note-ASTEROID-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>Putative beneficial effects of rosuvastatin therapy on chronic heart failure may be negated by increases in collagen turnover markers as well as a reduction in plasma <a href="Coenzyme_Q10.htm" tppabs="https://ptable.com/wiki/compounds/A/Coenzyme_Q10" title="Coenzyme Q10">coenzyme Q<sub>10</sub></a> levels in patients with chronic heart failure.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacodynamics">Pharmacodynamics</h2></summary>
    

<p>In a Cochrane systematic review the dose-related magnitude of rosuvastatin on blood lipids was determined. Over the dose range of 1 to 80<span>&nbsp;</span>mg/day strong linear dose‐related effects were found; total cholesterol was reduced by 22.1% to 44.8%, LDL cholesterol by 31.2% to 61.2%, non-HDL cholesterol by 28.9% to 56.7% and triglycerides by 14.4% to 26.6%.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    
<p>Absolute bioavailability of rosuvastatin is about 20% and C<sub>max</sub> is reached in 3 to 5 hours; administration with food did not affect the AUC according to the original sponsor submitted clinical study and as per product label.<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-9"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> However, a subsequent clinical study has shown a marked reduction in rosuvastatin exposure when administered with food.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> It is 88% protein bound, mainly to albumin.<span class="mw-ref" id="cite_ref-AHFS2018_3-15"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Fraction absorbed of rosuvastatin is frequently misquoted in the literature as approximately 0.5 (50%)<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> due to a miscalculated hepatic extraction ratio in the original submission package subsequently corrected by the FDA reviewer.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> It is likely that closer to 0.25 (25%) of the administered dose is absorbed.</p>

<p>Rosuvastatin is metabolized mainly by CYP2C9 and not extensively metabolized; approximately 10% is recovered as metabolite <i>N</i>-desmethyl rosuvastatin. It is excreted in feces (90%) primarily and the elimination half-life is approximately 19 hours.<span class="mw-ref" id="cite_ref-Crestor_FDA_label_4-10"><a href="#cite_note-Crestor_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2018_3-16"><a href="#cite_note-AHFS2018-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<p>Rosuvastatin is the international nonproprietary name (INN).<span class="mw-ref" id="cite_ref-INN_28-0"><a href="#cite_note-INN-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cost">Cost</h3></summary>
    
<p>Under provisions of the Patient Protection and Affordable Care Act (PPACA) in the United States, there is no cost for adults aged 40–75 years for rosuvastatin 5<span>&nbsp;</span>mg and 10<span>&nbsp;</span>mg based on United States Preventive Services Task Force (USPSTF) recommendations.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Indications_and_regulation">Indications and regulation</h3></summary>
    
<p>Rosuvastatin is approved in the United States for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia), and/or triglycerides (hypertriglyceridemia).<span class="mw-ref" id="cite_ref-pill_31-0"><a href="#cite_note-pill-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> In February 2010, rosuvastatin was approved by the FDA for the primary prevention of cardiovascular events.<span class="mw-ref" id="cite_ref-fdaap_32-0"><a href="#cite_note-fdaap-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>

<p><span>As of 2004</span>, rosuvastatin was approved in 154 countries and launched in 56. Approval in the United States by the Food and Drug Administration (FDA) came on 13 August 2003.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-FDAapproval_34-0"><a href="#cite_note-FDAapproval-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Patent_protection_and_generic_versions">Patent protection and generic versions</h3></summary>
    
<p>The main patent protecting rosuvastatin (RE37,314 — due to expire in 2016) was challenged as being an improper reissue of an earlier patent. This challenge was rejected in 2010, confirming protection until 2016.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>

<p>In April 2016, the FDA approved the first generic version of rosuvastatin (from Watson Pharmaceuticals Inc).<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> In July 2016, Mylan gained approval for its generic rosuvastatin calcium.<span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Marketing">Marketing</h3></summary>
    
<p>The drug was billed as a "super-statin" during its clinical development; the claim was that it offers high potency and improved cholesterol reduction compared to rivals in the class. The main competitors to rosuvastatin are <a href="Atorvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Atorvastatin" title="Atorvastatin">atorvastatin</a> and <a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">simvastatin</a>. However, people can also combine <a href="Ezetimibe.htm" tppabs="https://ptable.com/wiki/compounds/A/Ezetimibe" title="Ezetimibe">ezetimibe</a> with either simvastatin or atorvastatin and other agents on their own, for somewhat similar augmented response rates. <span>As of 2006</span> some published information for comparing rosuvastatin, atorvastatin, and ezetimibe/simvastatin results is available, but many of the relevant studies are still in progress.<span class="mw-ref" id="cite_ref-ASTEROID_22-1"><a href="#cite_note-ASTEROID-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>First launched in 2003, sales of rosuvastatin were $129<span class="nowrap"><span>&nbsp;</span></span>million and $908<span class="nowrap"><span>&nbsp;</span></span>million in 2003, and 2004, respectively, with a total patient treatment population of over four million by the end of 2004.
Annual cost to the UK National Health Service (NHS) in 2018 for 5–40<span>&nbsp;</span>mg rosuvastatin daily was £24-40, compared to £10-20 for 20–80<span>&nbsp;</span>mg simvastatin.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>In 2013, it was the fourth-highest selling drug in the United States, accounting for approximately $5.2<span class="nowrap"><span>&nbsp;</span></span>billion in sales.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Debate_and_criticisms">Debate and criticisms</h3></summary>
    
<p>In October 2003, several months after its introduction in Europe, Richard Horton, the editor of the medical journal <i>The Lancet</i>, criticized the way Crestor had been introduced. "AstraZeneca's tactics in marketing its cholesterol-lowering drug, rosuvastatin, raise disturbing questions about how drugs enter clinical practice and what measures exist to protect patients from inadequately investigated medicines," according to his editorial. <i>The Lancet's</i> editorial position is that the data for Crestor's superiority rely too much on extrapolation from the lipid profile data (surrogate end-points) and too little on hard clinical end-points, which are available for other statins that had been on the market longer. The manufacturer responded by stating that few drugs had been tested so successfully on so many patients. In correspondence published in <i>The Lancet</i>, AstraZeneca's CEO Sir Tom McKillop called the editorial "flawed and incorrect" and slammed the journal for making "such an outrageous critique of a serious, well-studied medicine."<span class="mw-ref" id="cite_ref-lancetoped_43-0"><a href="#cite_note-lancetoped-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>

<p>In 2004, the consumer interest organization Public Citizen filed a Citizen's Petition with the FDA, asking that Crestor be withdrawn from the US market. On 11 March 2005, the FDA issued a letter to Sidney M. Wolfe, M.D. of Public Citizen both denying the petition and providing an extensive detailed analysis of findings that demonstrated no basis for concerns about rosuvastatin compared with the other statins approved for marketing in the United States.<span class="mw-ref" id="cite_ref-FDA_ruling_44-0"><a href="#cite_note-FDA_ruling-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/rosuvastatin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/rosuvastatin.html'" tppabs="https://www.drugs.com/pregnancy/rosuvastatin.html" class="external text external">"Rosuvastatin Use During Pregnancy"</a>. <i>Drugs.com</i>. 27 September 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">14 March</span> 2020</span>.</cite></span></li><li id="cite_note-PK-2"> <span id="mw-reference-text-cite_note-PK-2" class="mw-reference-text"><cite id="CITEREFAggarwalShowkathali,_R2013" class="citation journal cs1">Aggarwal, RK; Showkathali, R (June 2013). <a href="javascript:if(confirm('https://semanticscholar.org/paper/a568d46e234e3510d8819d45122a2e8108896ca0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/a568d46e234e3510d8819d45122a2e8108896ca0'" tppabs="https://semanticscholar.org/paper/a568d46e234e3510d8819d45122a2e8108896ca0" class="external text external">"Rosuvastatin calcium in acute coronary syndromes"</a>. <i>Expert Opinion on Pharmacotherapy</i>. <b>14</b> (9): 1215–1227. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2013.789860  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2013.789860'" tppabs="https://doi.org/10.1517%2F14656566.2013.789860" class="external text external">10.1517/14656566.2013.789860</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23574635  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23574635'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23574635" class="external text external">23574635</a>.</cite></span></li><li id="cite_note-AHFS2018-3"> <span id="mw-reference-text-cite_note-AHFS2018-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/rosuvastatin-calcium.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/rosuvastatin-calcium.html'" tppabs="https://www.drugs.com/monograph/rosuvastatin-calcium.html" class="external text external">"Rosuvastatin Calcium Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists (AHFS)<span class="reference-accessdate">. Retrieved <span class="nowrap">24 December</span> 2018</span>.</cite></span></li><li id="cite_note-Crestor_FDA_label-4"> <span id="mw-reference-text-cite_note-Crestor_FDA_label-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb0f3b5e-4bc6-41c9-66b9-6257e2513512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb0f3b5e-4bc6-41c9-66b9-6257e2513512'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb0f3b5e-4bc6-41c9-66b9-6257e2513512" class="external text external">"Crestor- rosuvastatin calcium tablet, film coated"</a>. <i>DailyMed</i>. 9 November 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">14 March</span> 2020</span>.</cite></span></li><li id="cite_note-Fis2006-5"> <span id="mw-reference-text-cite_note-Fis2006-5" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Janos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA473'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA473" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>473. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">14 March</span> 2020</span>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Rosuvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Rosuvastatin'" tppabs="https://clincalc.com/DrugStats/Drugs/Rosuvastatin" class="external text external">"Rosuvastatin - Drug Usage Statistics"</a>. <i>ClinCalc</i>. 23 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-Jones-2003-8"> <span id="mw-reference-text-cite_note-Jones-2003-8" class="mw-reference-text"><cite id="CITEREFJonesDavidsonSteinBays2003" class="citation journal cs1">Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW (2003). "Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)". <i>Am J Cardiol</i>. <b>92</b> (2): 152–60. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0002-9149%2803%2900530-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0002-9149%2803%2900530-7'" tppabs="https://doi.org/10.1016%2FS0002-9149%2803%2900530-7" class="external text external">10.1016/S0002-9149(03)00530-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12860216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12860216'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12860216" class="external text external">12860216</a>.</cite></span></li><li id="cite_note-pmid=18553127-9"> <span id="mw-reference-text-cite_note-pmid=18553127-9" class="mw-reference-text"><cite id="CITEREFMcTaggart_F2008" class="citation journal cs1">McTaggart F (August 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493531'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493531" class="external text external">"Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit"</a>. <i>Cardiovasc Drugs Ther</i>. <b>22</b> (4): 321–38. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10557-008-6113-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10557-008-6113-z'" tppabs="https://doi.org/10.1007%2Fs10557-008-6113-z" class="external text external">10.1007/s10557-008-6113-z</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493531'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493531" class="external text external">2493531</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18553127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18553127'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18553127" class="external text external">18553127</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFAdamsSekhonWright2014" class="citation journal cs1">Adams, S. P.; Sekhon, S. S.; Wright, J. M. (November 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960" class="external text external">"Lipid-lowering efficacy of rosuvastatin"</a>. <i>Cochrane Database Syst Rev</i>. <b>11</b> (11): CD010254. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD010254.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD010254.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD010254.pub2" class="external text external">10.1002/14651858.CD010254.pub2</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960" class="external text external">6463960</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25415541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25415541'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25415541" class="external text external">25415541</a>.</cite></span></li><li id="cite_note-MedLine-11"> <span id="mw-reference-text-cite_note-MedLine-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.nlm.nih.gov/medlineplus/druginfo/meds/a603033.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nlm.nih.gov/medlineplus/druginfo/meds/a603033.html'" tppabs="https://www.nlm.nih.gov/medlineplus/druginfo/meds/a603033.html" class="external text external">"Rosuvastatin"</a>. <i>MedlinePlus</i>. U.S. National Library of Medicine. 15 June 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2012</span>.</cite></span></li><li id="cite_note-LactMed-12"> <span id="mw-reference-text-cite_note-LactMed-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20160107115521/http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?.%2Ftemp%2F~jLYVIr%3A1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160107115521/http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?.%2Ftemp%2F~jLYVIr%3A1'" tppabs="https://web.archive.org/web/20160107115521/http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?.%2Ftemp%2F~jLYVIr%3A1" class="external text external">"Rosuvastatin"</a>. <i>LactMed</i>. U.S. National Library of Medicine. Archived from <a href="javascript:if(confirm('http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~jLYVIr:1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~jLYVIr:1'" tppabs="http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~jLYVIr:1" class="external text external">the original</a> on 7 January 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2012</span>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFAlonso-Zaldivar2005" class="citation news cs1">Alonso-Zaldivar R (3 March 2005). <a href="javascript:if(confirm('https://www.latimes.com/archives/la-xpm-2005-mar-03-na-crestor3-story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.latimes.com/archives/la-xpm-2005-mar-03-na-crestor3-story.html'" tppabs="https://www.latimes.com/archives/la-xpm-2005-mar-03-na-crestor3-story.html" class="external text external">"FDA Advisory Targets Asian Patients"</a>. <i>Los Angeles Times</i>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFWuHristevaChangLiang2017" class="citation journal cs1">Wu HF, Hristeva N, Chang J, Liang X, Li R, Frassetto L, Benet LZ (September 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675025  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675025'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675025" class="external text external">"Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions"</a>. <i>J Pharm Sci</i>. <b>106</b> (9): 2751–2757. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.xphs.2017.03.027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.xphs.2017.03.027'" tppabs="https://doi.org/10.1016%2Fj.xphs.2017.03.027" class="external text external">10.1016/j.xphs.2017.03.027</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675025  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675025'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675025" class="external text external">5675025</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28385543  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28385543'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28385543" class="external text external">28385543</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFLeeChauLeungLee2009" class="citation journal cs1">Lee VW, Chau TS, Leung VP, Lee KK, Tomlinson B (December 2009). <a href="javascript:if(confirm('https://journals.lww.com/cmj/FullText/2009/12010/Clinical_efficacy_of_rosuvastatin_in_lipid.3.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://journals.lww.com/cmj/FullText/2009/12010/Clinical_efficacy_of_rosuvastatin_in_lipid.3.aspx'" tppabs="https://journals.lww.com/cmj/FullText/2009/12010/Clinical_efficacy_of_rosuvastatin_in_lipid.3.aspx" class="external text external">"Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong"</a>. <i>Chin. Med. J</i>. <b>122</b> (23): 2814–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20092783  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20092783'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20092783" class="external text external">20092783</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.webmd.com/cholesterol-management/news/20050303/fda-updates-crestor-warning-information  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.webmd.com/cholesterol-management/news/20050303/fda-updates-crestor-warning-information'" tppabs="https://www.webmd.com/cholesterol-management/news/20050303/fda-updates-crestor-warning-information" class="external text external">"FDA Updates Crestor Warning Information"</a>. <i>WebMD</i>. 3 March 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">14 March</span> 2020</span>.</cite></span></li><li id="cite_note-FDAlabel-17"> <span id="mw-reference-text-cite_note-FDAlabel-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20050305033448/https://www.fda.gov/cder/drug/infopage/rosuvastatin/default.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20050305033448/https://www.fda.gov/cder/drug/infopage/rosuvastatin/default.htm'" tppabs="https://web.archive.org/web/20050305033448/https://www.fda.gov/cder/drug/infopage/rosuvastatin/default.htm" class="external text external">"FDA Alert (03/2005) - Rosuvastatin Calcium (marketed as Crestor) Information"</a>. U.S. Food and Drug Administration (FDA). 14 March 2005. Archived from <a href="javascript:if(confirm('https://www.fda.gov/cder/drug/infopage/rosuvastatin/default.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/cder/drug/infopage/rosuvastatin/default.htm'" tppabs="https://www.fda.gov/cder/drug/infopage/rosuvastatin/default.htm" class="external text external">the original</a> on 5 March 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2005</span>.</cite> - This page is subject to change; the date reflects the last revision date.</span></li><li id="cite_note-FDA_Rosuvastatin_Safety-18"> <span id="mw-reference-text-cite_note-FDA_Rosuvastatin_Safety-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/rosuvastatin-calcium-marketed-crestor-information  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/rosuvastatin-calcium-marketed-crestor-information'" tppabs="http://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/rosuvastatin-calcium-marketed-crestor-information" class="external text external">"Rosuvastatin Calcium (marketed as Crestor) Information"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 10 July 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">14 March</span> 2020</span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFSattarPreiss,_DMurray,_HMWelsh,_P2010" class="citation journal cs1">Sattar, N; Preiss, D; Murray, HM; Welsh, P; Buckley, BM; de Craen, AJ; Seshasai, SR; McMurray, JJ; Freeman, DJ; Jukema, JW; Macfarlane, PW; Packard, CJ; Stott, DJ; Westendorp, RG; Shepherd, J; Davis, BR; Pressel, SL; Marchioli, R; Marfisi, RM; Maggioni, AP; Tavazzi, L; Tognoni, G; Kjekshus, J; Pedersen, TR; Cook, TJ; Gotto, AM; Clearfield, MB; Downs, JR; Nakamura, H; Ohashi, Y; Mizuno, K; Ray, KK; Ford, I (27 February 2010). "Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials". <i>Lancet</i>. <b>375</b> (9716): 735–42. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2809%2961965-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2809%2961965-6'" tppabs="https://doi.org/10.1016%2FS0140-6736%2809%2961965-6" class="external text external">10.1016/S0140-6736(09)61965-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20167359  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20167359'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20167359" class="external text external">20167359</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs'" tppabs="https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs" class="external text external">"FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs"</a>. U.S. Food and Drug Administration (FDA). 9 February 2019.</cite></span></li><li id="cite_note-Viberzi_FDA_label-21"> <span id="mw-reference-text-cite_note-Viberzi_FDA_label-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7821bd40-4c84-4984-951b-6436ae20421a  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7821bd40-4c84-4984-951b-6436ae20421a'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7821bd40-4c84-4984-951b-6436ae20421a" class="external text external">"Viberzi- eluxadoline tablet, film coated"</a>. <i>DailyMed</i>. 19 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">14 March</span> 2020</span>.</cite></span></li><li id="cite_note-ASTEROID-22"> <span id="mw-reference-text-cite_note-ASTEROID-22" class="mw-reference-text"><cite id="CITEREFNissenNichollsSipahi2006" class="citation journal cs1">Nissen SE, Nicholls SJ, Sipahi I,  et al. (2006). <a href="javascript:if(confirm('https://web.archive.org/web/20070929123259/http://jama.ama-assn.org/cgi/reprint/jama;295/13/1556.pdf?ijkey=Md42dlk7z9TzyL8&keytype=finite  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070929123259/http://jama.ama-assn.org/cgi/reprint/jama;295/13/1556.pdf?ijkey=Md42dlk7z9TzyL8&keytype=finite'" tppabs="https://web.archive.org/web/20070929123259/http://jama.ama-assn.org/cgi/reprint/jama;295/13/1556.pdf?ijkey=Md42dlk7z9TzyL8&keytype=finite" class="external text external">"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial"</a> <span class="cs1-format">(PDF)</span>. <i>JAMA</i>. <b>295</b> (13): 1556–65. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.295.13.jpc60002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.295.13.jpc60002'" tppabs="https://doi.org/10.1001%2Fjama.295.13.jpc60002" class="external text external">10.1001/jama.295.13.jpc60002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16533939  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16533939'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16533939" class="external text external">16533939</a>. Archived from <a href="javascript:if(confirm('http://jama.ama-assn.org/cgi/reprint/jama;295/13/1556.pdf?ijkey=Md42dlk7z9TzyL8&keytype=finite  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jama.ama-assn.org/cgi/reprint/jama;295/13/1556.pdf?ijkey=Md42dlk7z9TzyL8&keytype=finite'" tppabs="http://jama.ama-assn.org/cgi/reprint/jama;295/13/1556.pdf?ijkey=Md42dlk7z9TzyL8&keytype=finite" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 29 September 2007.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFAshtonWindebankSkiba2010" class="citation journal cs1">Ashton E, Windebank E, Skiba M,  et al. (January 2010). "Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study". <i>Int J Cardiol</i>. <b>146</b> (3): 404–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijcard.2009.12.028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijcard.2009.12.028'" tppabs="https://doi.org/10.1016%2Fj.ijcard.2009.12.028" class="external text external">10.1016/j.ijcard.2009.12.028</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20085851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20085851'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20085851" class="external text external">20085851</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite class="citation journal cs1">Adams, Stephen P.; Sekhon, Sarpreet S.; Wright, James M. (21 November 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960" class="external text external">"Rosuvastatin for lowering lipids. Cochrane Database of Systematic Reviews"</a>. <i>The Cochrane Database of Systematic Reviews</i>. John Wiley &amp; Sons, Ltd (11): CD010254. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.cd010254.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.cd010254.pub2'" tppabs="https://doi.org/10.1002%2F14651858.cd010254.pub2" class="external text external">10.1002/14651858.cd010254.pub2</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463960" class="external text external">6463960</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25415541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25415541'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25415541" class="external text external">25415541</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFLiJiangLanZhang2007" class="citation journal cs1">Li, Yunxia; Jiang, Xuehua; Lan, Ke; Zhang, Ruoqi; Li, Xue; Jiang, Qian (1 October 2007). <a href="javascript:if(confirm('http://www.clinicaltherapeutics.com/article/S0149-2918(07)00329-3/abstract  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.clinicaltherapeutics.com/article/S0149-2918(07)00329-3/abstract'" tppabs="http://www.clinicaltherapeutics.com/article/S0149-2918(07)00329-3/abstract" class="external text external">"Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study"</a>. <i>Clinical Therapeutics</i>. <b>29</b> (10): 2194–2203. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clinthera.2007.10.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clinthera.2007.10.005'" tppabs="https://doi.org/10.1016%2Fj.clinthera.2007.10.005" class="external text external">10.1016/j.clinthera.2007.10.005</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0149-2918  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0149-2918'" tppabs="https://www.worldcat.org/issn/0149-2918" class="external text external">0149-2918</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18042475  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18042475'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18042475" class="external text external">18042475</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFBergmanLundahlFridblomHedeland2009" class="citation journal cs1">Bergman, Ebba; Lundahl, Anna; Fridblom, Patrik; Hedeland, Mikael; Bondesson, Ulf; Knutson, Lars; Lennernäs, Hans (1 December 2009). <a href="javascript:if(confirm('https://semanticscholar.org/paper/48f3220f26bd94b7da71d6737464d86a8a3d8603  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/48f3220f26bd94b7da71d6737464d86a8a3d8603'" tppabs="https://semanticscholar.org/paper/48f3220f26bd94b7da71d6737464d86a8a3d8603" class="external text external">"Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil"</a>. <i>Drug Metabolism and Disposition</i>. <b>37</b> (12): 2349–2358. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fdmd.109.029363  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fdmd.109.029363'" tppabs="https://doi.org/10.1124%2Fdmd.109.029363" class="external text external">10.1124/dmd.109.029363</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1521-009X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1521-009X'" tppabs="https://www.worldcat.org/issn/1521-009X" class="external text external">1521-009X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19773540  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19773540'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19773540" class="external text external">19773540</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-366_Crestor.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-366_Crestor.cfm'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-366_Crestor.cfm" class="external text external">"Page 45 of FDA Drug Approval Package, Clinical Pharmacology Biopharmaceutics Review(s) (PDF)"</a>. U.S. Food and Drug Administration (FDA). 29 January 2004<span class="reference-accessdate">. Retrieved <span class="nowrap">22 June</span> 2016</span>.</cite></span></li><li id="cite_note-INN-28"> <span id="mw-reference-text-cite_note-INN-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.who.int/medicines/publications/druginformation/innlists/RL45.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/medicines/publications/druginformation/innlists/RL45.pdf'" tppabs="http://www.who.int/medicines/publications/druginformation/innlists/RL45.pdf" class="external text external">"International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 45"</a> <span class="cs1-format">(PDF)</span>. World Health Organization. 2001. p.<span>&nbsp;</span>50<span class="reference-accessdate">. Retrieved <span class="nowrap">29 November</span> 2016</span>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cigna.com/assets/docs/about-cigna/no-cost-share-preventive-medications.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cigna.com/assets/docs/about-cigna/no-cost-share-preventive-medications.pdf'" tppabs="https://www.cigna.com/assets/docs/about-cigna/no-cost-share-preventive-medications.pdf" class="external text external">"PPACA no cost-share preventive medications"</a> <span class="cs1-format">(PDF)</span>. Cigna<span class="reference-accessdate">. Retrieved <span class="nowrap">30 March</span> 2020</span>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://www.aafp.org/afp/2017/0115/od1.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.aafp.org/afp/2017/0115/od1.html'" tppabs="https://www.aafp.org/afp/2017/0115/od1.html" class="external text external">"Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement"</a>. <i>American Family Physician</i>. <b>95</b> (2). 15 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">31 March</span> 2020</span>.</cite></span></li><li id="cite_note-pill-31"> <span id="mw-reference-text-cite_note-pill-31" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20050508053622/http://www.crestor.info/gUserFiles/CRESTOR_CDS_10_40_mg_FINAL_170603.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20050508053622/http://www.crestor.info/gUserFiles/CRESTOR_CDS_10_40_mg_FINAL_170603.pdf'" tppabs="https://web.archive.org/web/20050508053622/http://www.crestor.info/gUserFiles/CRESTOR_CDS_10_40_mg_FINAL_170603.pdf" class="external text external">"Core Data Sheet, Crestor Tablets"</a> <span class="cs1-format">(PDF)</span>. AstraZeneca. June 17, 2003. Archived from <a href="javascript:if(confirm('http://www.crestor.info/gUserFiles/CRESTOR_CDS_10_40_mg_FINAL_170603.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.crestor.info/gUserFiles/CRESTOR_CDS_10_40_mg_FINAL_170603.pdf'" tppabs="http://www.crestor.info/gUserFiles/CRESTOR_CDS_10_40_mg_FINAL_170603.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on May 8, 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">March 20,</span> 2005</span>.</cite> - NOTE: this is provider-oriented information and should not be used without the supervision of a physician.</span></li><li id="cite_note-fdaap-32"> <span id="mw-reference-text-cite_note-fdaap-32" class="mw-reference-text"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021366s016ltr.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021366s016ltr.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021366s016ltr.pdf" class="external free external">http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021366s016ltr.pdf</a></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-366_Crestor.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-366_Crestor.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-366_Crestor.cfm" class="external text external">"Drug Approval Package: Crestor (Rosuvastatin Calcium) NDA #021366"</a>. <i>accessdata.fda.gov</i>. 29 January 2004<span class="reference-accessdate">. Retrieved <span class="nowrap">15 March</span> 2020</span>.</cite></span></li><li id="cite_note-FDAapproval-34"> <span id="mw-reference-text-cite_note-FDAapproval-34" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20050207153150/https://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01247.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20050207153150/https://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01247.html'" tppabs="https://web.archive.org/web/20050207153150/https://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01247.html" class="external text external">"FDA Approves New Drug for Lowering Cholesterol"</a>. Food and Drug Administration. 12 August 2003. Archived from <a href="javascript:if(confirm('https://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01247.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01247.html'" tppabs="https://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01247.html" class="external text external">the original</a> on 7 February 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2005</span>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.delawareonline.com/article/20100701/BUSINESS/7010316/1003/RSS01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.delawareonline.com/article/20100701/BUSINESS/7010316/1003/RSS01'" tppabs="http://www.delawareonline.com/article/20100701/BUSINESS/7010316/1003/RSS01" class="external text external">"AstraZeneca's Crestor patent upheld;No generic competition until 2016"</a>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://www.prnewswire.com/news-releases/crestor-patent-upheld-by-us-court-97435724.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.prnewswire.com/news-releases/crestor-patent-upheld-by-us-court-97435724.html'" tppabs="https://www.prnewswire.com/news-releases/crestor-patent-upheld-by-us-court-97435724.html" class="external text external">"Crestor Patent Upheld By US Court"</a> (Press release). AstraZeneca. 29 June 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2012</span> <span>–</span> via PR Newswire.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFBerkrotHals2010" class="citation news cs1">Berkrot, Bill; Hals, Tom (29 June 2010). <a href="javascript:if(confirm('https://www.reuters.com/article/2010/06/29/astrazeneca-crestor-idUSN2917115320100629  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/2010/06/29/astrazeneca-crestor-idUSN2917115320100629'" tppabs="https://www.reuters.com/article/2010/06/29/astrazeneca-crestor-idUSN2917115320100629" class="external text external">"U.S. judge rules AstraZeneca Crestor patent valid"</a>. Reuters<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2012</span>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFStarkey2010" class="citation news cs1">Starkey, Jonathan (1 July 2010). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://pqasb.pqarchiver.com/delawareonline/access/2074695931.html?FMT=ABS&date=Jul+01%2C+2010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pqasb.pqarchiver.com/delawareonline/access/2074695931.html?FMT=ABS&date=Jul+01%2C+2010'" tppabs="https://pqasb.pqarchiver.com/delawareonline/access/2074695931.html?FMT=ABS&date=Jul+01%2C+2010" class="external text external">"AstraZeneca patent upheld"</a></span>. <i>The News Journal</i>. Wilmington, Delaware<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2012</span>.</cite> <span style="font-size:0.95em; font-size:90%; color:#555">(subscription required)</span></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-crestor  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-crestor'" tppabs="https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-crestor" class="external text external">"FDA approves first generic Crestor"</a>. Food and Drug Administration. 29 April 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">3 May</span> 2016</span>.</cite></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://www.prnewswire.com/news-releases/mylan-launches-generic-crestor-tablets-300301446.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.prnewswire.com/news-releases/mylan-launches-generic-crestor-tablets-300301446.html'" tppabs="https://www.prnewswire.com/news-releases/mylan-launches-generic-crestor-tablets-300301446.html" class="external text external">"Mylan Launches Generic Crestor Tablets"</a> (Press release). Mylan. 20 July 2016 <span>–</span> via PR Newswire.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://gmmmg.nhs.uk/docs/cost_comparison_charts.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://gmmmg.nhs.uk/docs/cost_comparison_charts.pdf'" tppabs="http://gmmmg.nhs.uk/docs/cost_comparison_charts.pdf" class="external text external">"COST COMPARISON CHARTS"</a> <span class="cs1-format">(PDF)</span>. REGIONAL DRUG AND THERAPEUTICS CENTRE (NEWCASTLE). August 2018.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/stats/top100/sales  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/stats/top100/sales'" tppabs="https://www.drugs.com/stats/top100/sales" class="external text external">"Top 100 Drugs for Q2 2013 by Sales"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">24 August</span> 2013</span>.</cite></span></li><li id="cite_note-lancetoped-43"> <span id="mw-reference-text-cite_note-lancetoped-43" class="mw-reference-text"><cite id="CITEREFHorton,_Richard2003" class="citation journal cs1">Horton, Richard (25 October 2003). "The statin wars: why AstraZeneca must retreat". <i>Lancet</i>. <b>362</b> (9393): 1341. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2803%2914669-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2803%2914669-7'" tppabs="https://doi.org/10.1016%2FS0140-6736%2803%2914669-7" class="external text external">10.1016/S0140-6736(03)14669-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14585629  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14585629'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14585629" class="external text external">14585629</a>.</cite><br><cite id="CITEREFMcKillop_T2003" class="citation journal cs1">McKillop T (1 November 2003). "The statin wars". <i>Lancet</i>. <b>362</b> (9394): 1498. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2803%2914698-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2803%2914698-3'" tppabs="https://doi.org/10.1016%2FS0140-6736%2803%2914698-3" class="external text external">10.1016/S0140-6736(03)14698-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14602449  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14602449'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14602449" class="external text external">14602449</a>.</cite></span></li><li id="cite_note-FDA_ruling-44"> <span id="mw-reference-text-cite_note-FDA_ruling-44" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.regulations.gov/contentStreamer?documentId=FDA-2004-P-0009-0004&attachmentNumber=1&contentType=pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.regulations.gov/contentStreamer?documentId=FDA-2004-P-0009-0004&attachmentNumber=1&contentType=pdf'" tppabs="https://www.regulations.gov/contentStreamer?documentId=FDA-2004-P-0009-0004&attachmentNumber=1&contentType=pdf" class="external text external">"Docket No. 2004P-0113/CP1"</a>. Food and Drug Administration.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/rosuvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/rosuvastatin'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/rosuvastatin" class="external text external">"Rosuvastatin"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Lipid-modifying_agents_(C10)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Lipid-modifying_agents_(C10)" style="font-size:114%;margin:0 4em">Lipid-modifying agents (C10)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">GI tract</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Cholesterol absorption inhibitors, NPC1L1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ezetimibe.htm" tppabs="https://ptable.com/wiki/compounds/A/Ezetimibe" title="Ezetimibe">Ezetimibe</a></li>
<li>SCH-48461</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Bile acid sequestrants/resins (LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Colesevelam.htm" tppabs="https://ptable.com/wiki/compounds/A/Colesevelam" title="Colesevelam">Colesevelam</a></li>
<li>Colestilan</li>
<li><a href="Colestipol.htm" tppabs="https://ptable.com/wiki/compounds/A/Colestipol" title="Colestipol">Colestipol</a></li>
<li>Colestyramine</li>
<li>Colextran</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Liver</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Statins (HMG-CoA reductase, LDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atorvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Atorvastatin" title="Atorvastatin">Atorvastatin</a></li>
<li><a href="Cerivastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cerivastatin" title="Cerivastatin">Cerivastatin</a><sup>‡</sup></li>
<li><a href="Fluvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvastatin" title="Fluvastatin">Fluvastatin</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li><a href="Mevastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li>Pitavastatin</li>
<li><a href="Pravastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pravastatin" title="Pravastatin">Pravastatin</a></li>
<li><a href="Rosuvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosuvastatin" title="Rosuvastatin">Rosuvastatin</a></li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Niacin and derivatives (HDL and LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acipimox</li>
<li>Aluminium nicotinate</li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a></li>
<li>Niceritrol</li>
<li><a href="Nicofuranose.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicofuranose" title="Nicofuranose">Nicofuranose</a></li>
<li><a href="Nicotinyl_alcohol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinyl_alcohol" title="Nicotinyl alcohol">Nicotinyl alcohol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MTTP inhibitors (VLDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dirlotapide</li>
<li>Lomitapide</li>
<li>Mitratapide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">ATP citrate lyase inhibitors (LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bempedoic acid</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Blood vessels</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Fibrates (PPAR)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aluminium clofibrate</li>
<li><a href="Bezafibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezafibrate" title="Bezafibrate">Bezafibrate</a></li>
<li><span class="new">Choline fenofibrate</span></li>
<li><a href="Ciprofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciprofibrate" title="Ciprofibrate">Ciprofibrate</a></li>
<li>Clinofibrate</li>
<li><a href="Clofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofibrate" title="Clofibrate">Clofibrate</a><sup>‡</sup></li>
<li>Clofibride</li>
<li>Etofibrate</li>
<li><a href="Fenofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenofibrate" title="Fenofibrate">Fenofibrate</a></li>
<li><a href="Gemfibrozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemfibrozil" title="Gemfibrozil">Gemfibrozil</a></li>
<li>Pemafibrate</li>
<li>Ronifibrate</li>
<li>Simfibrate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CETP inhibitors (HDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Anacetrapib<sup>†</sup></li>
<li>Dalcetrapib<sup>§</sup></li>
<li>Evacetrapib<sup>§</sup></li>
<li><span class="new">Obicetrapib</span><sup>†</sup></li>
<li>Torcetrapib<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">PCSK9 inhibitors (LDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alirocumab</li>
<li>Bococizumab</li>
<li>Evolocumab</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bempedoic acid/ezetimibe</li>
<li>Ezetimibe/atorvastatin</li>
<li>Ezetimibe/rosuvastatin</li>
<li>Ezetimibe/simvastatin</li>
<li>Fenofibrate/pravastatin</li>
<li>Fenofibrate/simvastatin</li>
<li>Niacin/laropiprant</li>
<li>Niacin/lovastatin</li>
<li>Niacin/simvastatin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alipogene tiparvovec</li>
<li>Azacosterol</li>
<li>Azalanstat</li>
<li>Benfluorex<sup>‡</sup></li>
<li>Darapladib<sup>§</sup></li>
<li><a href="Dextrothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextrothyroxine" title="Dextrothyroxine">Dextrothyroxine</a><sup>‡</sup></li>
<li>Lapaquistat<sup>§</sup></li>
<li>Magnesium pyridoxal 5-phosphate glutamate</li>
<li><a href="Meglutol.htm" tppabs="https://ptable.com/wiki/compounds/A/Meglutol" title="Meglutol">Meglutol</a></li>
<li>Mipomersen</li>
<li>Omega-3-triglycerides</li>
<li>Policosanol</li>
<li><a href="Probucol.htm" tppabs="https://ptable.com/wiki/compounds/A/Probucol" title="Probucol">Probucol</a></li>
<li>Tiadenol</li>
<li>Triparanol<sup>‡</sup></li>
<li>Volanesorsen</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="AstraZeneca" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="AstraZeneca" style="font-size:114%;margin:0 4em">AstraZeneca</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="Atenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Atenolol" title="Atenolol">Atenolol</a></li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">Brompheniramine</a></li>
<li><a href="Budesonide.htm" tppabs="https://ptable.com/wiki/compounds/A/Budesonide" title="Budesonide">Budesonide</a></li>
<li>Disufenton sodium</li>
<li><a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">Esomeprazole</a></li>
<li>FluMist</li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li>
<li><a href="Gefitinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Gefitinib" title="Gefitinib">Gefitinib</a></li>
<li><a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">Goserelin</a></li>
<li><a href="Isosorbide_mononitrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Isosorbide_mononitrate" title="Isosorbide mononitrate">Isosorbide mononitrate</a></li>
<li>Motavizumab</li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li>Palivizumab</li>
<li><a href="Propofol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propofol" title="Propofol">Propofol</a></li>
<li><a href="Rosuvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosuvastatin" title="Rosuvastatin">Rosuvastatin</a></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>Ticagrelor</li>
<li>Vandetanib</li>
<li><a href="Ximelagatran.htm" tppabs="https://ptable.com/wiki/compounds/A/Ximelagatran" title="Ximelagatran">Ximelagatran</a></li>
<li><a href="Zafirlukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">Zolmitriptan</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Predecessors and<br>acquired companies</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Astra AB</li>
<li>Cambridge Antibody Technology</li>
<li>MedImmune</li>
<li>Zeneca</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">People</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tom McKillop</li>
<li>Louis Schweitzer</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="font-weight: bold;"><div>
<ul><li><figure-inline><span><img src="../I/m/Folder_Hexagonal_Icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Folder_Hexagonal_Icon.svg.png" data-file-width="36" data-file-height="31" data-file-type="drawing" height="14" width="16"></span></figure-inline> Category</li>
<li><figure-inline><span><img src="../I/m/Commons-logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="16" width="12"></span></figure-inline> <a href="javascript:if(confirm('https://commons.wikimedia.org/wiki/Category:AstraZeneca  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://commons.wikimedia.org/wiki/Category:AstraZeneca'" tppabs="https://commons.wikimedia.org/wiki/Category:AstraZeneca" title="commons:Category:AstraZeneca" class="external">Commons</a></li></ul>
</div></td></tr></tbody></table></div>











<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-04" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Rosuvastatin&oldid=971093327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Rosuvastatin&oldid=971093327'" tppabs="https://en.wikipedia.org/wiki/?title=Rosuvastatin&oldid=971093327">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>